CONTEXT: X-linked hypophosphatemia (XLH) is a rare genetic disease, characterized by renal phosphate wasting and complex musculoskeletal manifestations including decreased physical performance. OBJECTIVE: To characterize muscular deficits in XLH patients and investigate phosphate stores of the muscle. DESIGN: Case-control study (MuXLiH) with a one-time assessment at the German Aerospace Center (DLR), Cologne, from May to December 2019. SETTING: XLH patients cared for at the Osteology Department, University of Wuerzburg. PATIENTS AND PARTICIPANTS: 13 XLH patients and 13 age\/sex\/body weight matched controls aged 18 to 65 years. MAIN OUTCOME MEASURES: 31P magnetic resonance spectroscopy (31P-MRS) based assessment of phosphate metabolites in the soleus muscle at rest. Further analyses included MRI-based muscle volume measurement, laboratory testing, isokinetic maximum voluntary contraction (MVC), fatigue testing and jumping mechanography. RESULTS: By means of 31P-MRS, no significant differences were observed between XLH and controls regarding phosphate metabolites except for a slightly increased phosphocreatine to inorganic phosphate (PCr\/Pi) ratio (XLH: 13.44 +\/- 3.22, control: 11.01 +\/- 2.62, p = 0.023). Quadriceps muscle volume was reduced in XLH (XLH: 812.1 +\/- 309.0 ml, control: 1391.1 +\/- 306.2 mv, p < 0.001). No significant differences were observed regarding isokinetic maximum torque (MVC) adjusted to quadriceps muscle volume. Jumping peak power and jump height were significantly reduced in XLH vs. controls (both p < 0.001). CONCLUSION: The content of phosphoric compounds within the musculature of XLH patients was not observed to be different from controls. Volume-adjusted muscle strength and fatiguability were not different, either. Reduced physical performance in XLH patients may result from long-term adaptation to reduced physical activity due to skeletal impairment.\n<\/p>\n","protected":false},"excerpt":{"rendered":"
CONTEXT: X-linked hypophosphatemia (XLH) is a rare genetic disease, characterized by renal phosphate wasting and complex musculoskeletal manifestations including decreased<\/p>\n","protected":false},"author":22,"parent":0,"menu_order":0,"template":"","format":"standard","meta":{"_acf_changed":false},"tags":[],"thema":[5924,5866],"produktgruppe":[5827],"literatur_kategorie":[7221],"class_list":["post-166648","literatur","type-literatur","status-publish","format-standard","hentry","thema-clinical-studies","thema-diagnostics-using-leonardo-pqct","produktgruppe-leonardo-en","literatur_kategorie-clinical-studies"],"acf":[],"_links":{"self":[{"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/literatur\/166648","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/literatur"}],"about":[{"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/types\/literatur"}],"author":[{"embeddable":true,"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/users\/22"}],"version-history":[{"count":0,"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/literatur\/166648\/revisions"}],"wp:attachment":[{"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/media?parent=166648"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/tags?post=166648"},{"taxonomy":"thema","embeddable":true,"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/thema?post=166648"},{"taxonomy":"produktgruppe","embeddable":true,"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/produktgruppe?post=166648"},{"taxonomy":"literatur_kategorie","embeddable":true,"href":"https:\/\/stratec-med.com\/en\/wp-json\/wp\/v2\/literatur_kategorie?post=166648"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}